img

Global CAR-T Cell Immunotherapies for Cancer Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global CAR-T Cell Immunotherapies for Cancer Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal CAR-T Cell Immunotherapies for Cancer Market
Global CAR-T Cell Immunotherapies for Cancer market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, CAR-T Cell Immunotherapies for Cancer industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global CAR-T Cell Immunotherapies for Cancer market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global CAR-T Cell Immunotherapies for Cancer market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


NOVARTIS
Penn
Fosun Pharma
Celgene Corporation
Legend Biotech
SHEBA
JW Therapeutics
Protheragen
EXUMA Biotechnology
Segment by Type
CD19
BCMA
EPCAM

Segment by Application


Hematological Cancer
Solid Tumor
Other Oncological Disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, CAR-T Cell Immunotherapies for Cancer introduction, etc. CAR-T Cell Immunotherapies for Cancer Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of CAR-T Cell Immunotherapies for Cancer
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 CD19
1.2.3 BCMA
1.2.4 EPCAM
1.3 Market by Application
1.3.1 Global CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hematological Cancer
1.3.3 Solid Tumor
1.3.4 Other Oncological Disorders
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Cell Immunotherapies for Cancer Market Perspective (2018-2033)
2.2 Global CAR-T Cell Immunotherapies for Cancer Growth Trends by Region
2.2.1 CAR-T Cell Immunotherapies for Cancer Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 CAR-T Cell Immunotherapies for Cancer Historic Market Size by Region (2018-2023)
2.2.3 CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Region (2024-2033)
2.3 CAR-T Cell Immunotherapies for Cancer Market Dynamics
2.3.1 CAR-T Cell Immunotherapies for Cancer Industry Trends
2.3.2 CAR-T Cell Immunotherapies for Cancer Market Drivers
2.3.3 CAR-T Cell Immunotherapies for Cancer Market Challenges
2.3.4 CAR-T Cell Immunotherapies for Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CAR-T Cell Immunotherapies for Cancer by Players
3.1.1 Global CAR-T Cell Immunotherapies for Cancer Revenue by Players (2018-2023)
3.1.2 Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Players (2018-2023)
3.2 Global CAR-T Cell Immunotherapies for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CAR-T Cell Immunotherapies for Cancer, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global CAR-T Cell Immunotherapies for Cancer Market Concentration Ratio
3.4.1 Global CAR-T Cell Immunotherapies for Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Cell Immunotherapies for Cancer Revenue in 2022
3.5 Global Key Players of CAR-T Cell Immunotherapies for Cancer Head office and Area Served
3.6 Global Key Players of CAR-T Cell Immunotherapies for Cancer, Product and Application
3.7 Global Key Players of CAR-T Cell Immunotherapies for Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T Cell Immunotherapies for Cancer Breakdown Data by Type
4.1 Global CAR-T Cell Immunotherapies for Cancer Historic Market Size by Type (2018-2023)
4.2 Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Type (2024-2033)
5 CAR-T Cell Immunotherapies for Cancer Breakdown Data by Application
5.1 Global CAR-T Cell Immunotherapies for Cancer Historic Market Size by Application (2018-2023)
5.2 Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America CAR-T Cell Immunotherapies for Cancer Market Size (2018-2033)
6.2 North America CAR-T Cell Immunotherapies for Cancer Market Size by Type
6.2.1 North America CAR-T Cell Immunotherapies for Cancer Market Size by Type (2018-2023)
6.2.2 North America CAR-T Cell Immunotherapies for Cancer Market Size by Type (2024-2033)
6.2.3 North America CAR-T Cell Immunotherapies for Cancer Market Share by Type (2018-2033)
6.3 North America CAR-T Cell Immunotherapies for Cancer Market Size by Application
6.3.1 North America CAR-T Cell Immunotherapies for Cancer Market Size by Application (2018-2023)
6.3.2 North America CAR-T Cell Immunotherapies for Cancer Market Size by Application (2024-2033)
6.3.3 North America CAR-T Cell Immunotherapies for Cancer Market Share by Application (2018-2033)
6.4 North America CAR-T Cell Immunotherapies for Cancer Market Size by Country
6.4.1 North America CAR-T Cell Immunotherapies for Cancer Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023)
6.4.3 North America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe CAR-T Cell Immunotherapies for Cancer Market Size (2018-2033)
7.2 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Type
7.2.1 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Type (2018-2023)
7.2.2 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Type (2024-2033)
7.2.3 Europe CAR-T Cell Immunotherapies for Cancer Market Share by Type (2018-2033)
7.3 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Application
7.3.1 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Application (2018-2023)
7.3.2 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Application (2024-2033)
7.3.3 Europe CAR-T Cell Immunotherapies for Cancer Market Share by Application (2018-2033)
7.4 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country
7.4.1 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023)
7.4.3 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CAR-T Cell Immunotherapies for Cancer Market Size (2018-2033)
8.2 China CAR-T Cell Immunotherapies for Cancer Market Size by Type
8.2.1 China CAR-T Cell Immunotherapies for Cancer Market Size by Type (2018-2023)
8.2.2 China CAR-T Cell Immunotherapies for Cancer Market Size by Type (2024-2033)
8.2.3 China CAR-T Cell Immunotherapies for Cancer Market Share by Type (2018-2033)
8.3 China CAR-T Cell Immunotherapies for Cancer Market Size by Application
8.3.1 China CAR-T Cell Immunotherapies for Cancer Market Size by Application (2018-2023)
8.3.2 China CAR-T Cell Immunotherapies for Cancer Market Size by Application (2024-2033)
8.3.3 China CAR-T Cell Immunotherapies for Cancer Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia CAR-T Cell Immunotherapies for Cancer Market Size (2018-2033)
9.2 Asia CAR-T Cell Immunotherapies for Cancer Market Size by Type
9.2.1 Asia CAR-T Cell Immunotherapies for Cancer Market Size by Type (2018-2023)
9.2.2 Asia CAR-T Cell Immunotherapies for Cancer Market Size by Type (2024-2033)
9.2.3 Asia CAR-T Cell Immunotherapies for Cancer Market Share by Type (2018-2033)
9.3 Asia CAR-T Cell Immunotherapies for Cancer Market Size by Application
9.3.1 Asia CAR-T Cell Immunotherapies for Cancer Market Size by Application (2018-2023)
9.3.2 Asia CAR-T Cell Immunotherapies for Cancer Market Size by Application (2024-2033)
9.3.3 Asia CAR-T Cell Immunotherapies for Cancer Market Share by Application (2018-2033)
9.4 Asia CAR-T Cell Immunotherapies for Cancer Market Size by Region
9.4.1 Asia CAR-T Cell Immunotherapies for Cancer Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia CAR-T Cell Immunotherapies for Cancer Market Size by Region (2018-2023)
9.4.3 Asia CAR-T Cell Immunotherapies for Cancer Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Type
10.2.1 Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Application
10.3.1 Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country
10.4.1 Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 NOVARTIS
11.1.1 NOVARTIS Company Details
11.1.2 NOVARTIS Business Overview
11.1.3 NOVARTIS CAR-T Cell Immunotherapies for Cancer Introduction
11.1.4 NOVARTIS Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.1.5 NOVARTIS Recent Developments
11.2 Penn
11.2.1 Penn Company Details
11.2.2 Penn Business Overview
11.2.3 Penn CAR-T Cell Immunotherapies for Cancer Introduction
11.2.4 Penn Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.2.5 Penn Recent Developments
11.3 Fosun Pharma
11.3.1 Fosun Pharma Company Details
11.3.2 Fosun Pharma Business Overview
11.3.3 Fosun Pharma CAR-T Cell Immunotherapies for Cancer Introduction
11.3.4 Fosun Pharma Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.3.5 Fosun Pharma Recent Developments
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Details
11.4.2 Celgene Corporation Business Overview
11.4.3 Celgene Corporation CAR-T Cell Immunotherapies for Cancer Introduction
11.4.4 Celgene Corporation Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.4.5 Celgene Corporation Recent Developments
11.5 Legend Biotech
11.5.1 Legend Biotech Company Details
11.5.2 Legend Biotech Business Overview
11.5.3 Legend Biotech CAR-T Cell Immunotherapies for Cancer Introduction
11.5.4 Legend Biotech Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.5.5 Legend Biotech Recent Developments
11.6 SHEBA
11.6.1 SHEBA Company Details
11.6.2 SHEBA Business Overview
11.6.3 SHEBA CAR-T Cell Immunotherapies for Cancer Introduction
11.6.4 SHEBA Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.6.5 SHEBA Recent Developments
11.7 JW Therapeutics
11.7.1 JW Therapeutics Company Details
11.7.2 JW Therapeutics Business Overview
11.7.3 JW Therapeutics CAR-T Cell Immunotherapies for Cancer Introduction
11.7.4 JW Therapeutics Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.7.5 JW Therapeutics Recent Developments
11.8 Protheragen
11.8.1 Protheragen Company Details
11.8.2 Protheragen Business Overview
11.8.3 Protheragen CAR-T Cell Immunotherapies for Cancer Introduction
11.8.4 Protheragen Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.8.5 Protheragen Recent Developments
11.9 EXUMA Biotechnology
11.9.1 EXUMA Biotechnology Company Details
11.9.2 EXUMA Biotechnology Business Overview
11.9.3 EXUMA Biotechnology CAR-T Cell Immunotherapies for Cancer Introduction
11.9.4 EXUMA Biotechnology Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
11.9.5 EXUMA Biotechnology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of CD19
Table 3. Key Players of BCMA
Table 4. Key Players of EPCAM
Table 5. Global CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global CAR-T Cell Immunotherapies for Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global CAR-T Cell Immunotherapies for Cancer Market Share by Region (2018-2023)
Table 9. Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global CAR-T Cell Immunotherapies for Cancer Market Share by Region (2024-2033)
Table 11. CAR-T Cell Immunotherapies for Cancer Market Trends
Table 12. CAR-T Cell Immunotherapies for Cancer Market Drivers
Table 13. CAR-T Cell Immunotherapies for Cancer Market Challenges
Table 14. CAR-T Cell Immunotherapies for Cancer Market Restraints
Table 15. Global CAR-T Cell Immunotherapies for Cancer Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global CAR-T Cell Immunotherapies for Cancer Revenue Share by Players (2018-2023)
Table 17. Global Top CAR-T Cell Immunotherapies for Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Immunotherapies for Cancer as of 2022)
Table 18. Global CAR-T Cell Immunotherapies for Cancer Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by CAR-T Cell Immunotherapies for Cancer Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of CAR-T Cell Immunotherapies for Cancer, Headquarters and Area Served
Table 21. Global Key Players of CAR-T Cell Immunotherapies for Cancer, Product and Application
Table 22. Global Key Players of CAR-T Cell Immunotherapies for Cancer, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global CAR-T Cell Immunotherapies for Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Type (2018-2023)
Table 26. Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Type (2024-2033)
Table 28. Global CAR-T Cell Immunotherapies for Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global CAR-T Cell Immunotherapies for Cancer Revenue Share by Application (2018-2023)
Table 30. Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global CAR-T Cell Immunotherapies for Cancer Revenue Share by Application (2024-2033)
Table 32. North America CAR-T Cell Immunotherapies for Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America CAR-T Cell Immunotherapies for Cancer Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America CAR-T Cell Immunotherapies for Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America CAR-T Cell Immunotherapies for Cancer Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America CAR-T Cell Immunotherapies for Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe CAR-T Cell Immunotherapies for Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe CAR-T Cell Immunotherapies for Cancer Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe CAR-T Cell Immunotherapies for Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe CAR-T Cell Immunotherapies for Cancer Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe CAR-T Cell Immunotherapies for Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 46. China CAR-T Cell Immunotherapies for Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 47. China CAR-T Cell Immunotherapies for Cancer Market Size by Type (2024-2033) & (US$ Million)
Table 48. China CAR-T Cell Immunotherapies for Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 49. China CAR-T Cell Immunotherapies for Cancer Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia CAR-T Cell Immunotherapies for Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia CAR-T Cell Immunotherapies for Cancer Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia CAR-T Cell Immunotherapies for Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia CAR-T Cell Immunotherapies for Cancer Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia CAR-T Cell Immunotherapies for Cancer Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia CAR-T Cell Immunotherapies for Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia CAR-T Cell Immunotherapies for Cancer Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 64. NOVARTIS Company Details
Table 65. NOVARTIS Business Overview
Table 66. NOVARTIS CAR-T Cell Immunotherapies for Cancer Product
Table 67. NOVARTIS Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 68. NOVARTIS Recent Developments
Table 69. Penn Company Details
Table 70. Penn Business Overview
Table 71. Penn CAR-T Cell Immunotherapies for Cancer Product
Table 72. Penn Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 73. Penn Recent Developments
Table 74. Fosun Pharma Company Details
Table 75. Fosun Pharma Business Overview
Table 76. Fosun Pharma CAR-T Cell Immunotherapies for Cancer Product
Table 77. Fosun Pharma Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 78. Fosun Pharma Recent Developments
Table 79. Celgene Corporation Company Details
Table 80. Celgene Corporation Business Overview
Table 81. Celgene Corporation CAR-T Cell Immunotherapies for Cancer Product
Table 82. Celgene Corporation Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 83. Celgene Corporation Recent Developments
Table 84. Legend Biotech Company Details
Table 85. Legend Biotech Business Overview
Table 86. Legend Biotech CAR-T Cell Immunotherapies for Cancer Product
Table 87. Legend Biotech Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 88. Legend Biotech Recent Developments
Table 89. SHEBA Company Details
Table 90. SHEBA Business Overview
Table 91. SHEBA CAR-T Cell Immunotherapies for Cancer Product
Table 92. SHEBA Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 93. SHEBA Recent Developments
Table 94. JW Therapeutics Company Details
Table 95. JW Therapeutics Business Overview
Table 96. JW Therapeutics CAR-T Cell Immunotherapies for Cancer Product
Table 97. JW Therapeutics Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 98. JW Therapeutics Recent Developments
Table 99. Protheragen Company Details
Table 100. Protheragen Business Overview
Table 101. Protheragen CAR-T Cell Immunotherapies for Cancer Product
Table 102. Protheragen Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 103. Protheragen Recent Developments
Table 104. EXUMA Biotechnology Company Details
Table 105. EXUMA Biotechnology Business Overview
Table 106. EXUMA Biotechnology CAR-T Cell Immunotherapies for Cancer Product
Table 107. EXUMA Biotechnology Revenue in CAR-T Cell Immunotherapies for Cancer Business (2018-2023) & (US$ Million)
Table 108. EXUMA Biotechnology Recent Developments
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global CAR-T Cell Immunotherapies for Cancer Market Share by Type: 2022 VS 2033
Figure 3. CD19 Features
Figure 4. BCMA Features
Figure 5. EPCAM Features
Figure 6. Global CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global CAR-T Cell Immunotherapies for Cancer Market Share by Application: 2022 VS 2033
Figure 8. Hematological Cancer Case Studies
Figure 9. Solid Tumor Case Studies
Figure 10. Other Oncological Disorders Case Studies
Figure 11. CAR-T Cell Immunotherapies for Cancer Report Years Considered
Figure 12. Global CAR-T Cell Immunotherapies for Cancer Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global CAR-T Cell Immunotherapies for Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global CAR-T Cell Immunotherapies for Cancer Market Share by Region: 2022 VS 2033
Figure 15. Global CAR-T Cell Immunotherapies for Cancer Market Share by Players in 2022
Figure 16. Global Top CAR-T Cell Immunotherapies for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Immunotherapies for Cancer as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by CAR-T Cell Immunotherapies for Cancer Revenue in 2022
Figure 18. North America CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America CAR-T Cell Immunotherapies for Cancer Market Share by Type (2018-2033)
Figure 20. North America CAR-T Cell Immunotherapies for Cancer Market Share by Application (2018-2033)
Figure 21. North America CAR-T Cell Immunotherapies for Cancer Market Share by Country (2018-2033)
Figure 22. United States CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe CAR-T Cell Immunotherapies for Cancer Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe CAR-T Cell Immunotherapies for Cancer Market Share by Type (2018-2033)
Figure 26. Europe CAR-T Cell Immunotherapies for Cancer Market Share by Application (2018-2033)
Figure 27. Europe CAR-T Cell Immunotherapies for Cancer Market Share by Country (2018-2033)
Figure 28. Germany CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China CAR-T Cell Immunotherapies for Cancer Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China CAR-T Cell Immunotherapies for Cancer Market Share by Type (2018-2033)
Figure 36. China CAR-T Cell Immunotherapies for Cancer Market Share by Application (2018-2033)
Figure 37. Asia CAR-T Cell Immunotherapies for Cancer Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia CAR-T Cell Immunotherapies for Cancer Market Share by Type (2018-2033)
Figure 39. Asia CAR-T Cell Immunotherapies for Cancer Market Share by Application (2018-2033)
Figure 40. Asia CAR-T Cell Immunotherapies for Cancer Market Share by Region (2018-2033)
Figure 41. Japan CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America CAR-T Cell Immunotherapies for Cancer Market Share by Country (2018-2033)
Figure 51. Brazil CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. NOVARTIS Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 58. Penn Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 59. Fosun Pharma Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 60. Celgene Corporation Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 61. Legend Biotech Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 62. SHEBA Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 63. JW Therapeutics Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 64. Protheragen Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 65. EXUMA Biotechnology Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries